^
    Back
    Association details:
    Biomarker:MGMT underexpression
    Cancer:Glioblastoma
    Drug:temozolomide (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    Source:
    J Neurooncol
    Title:

    Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide

    Published date:
    01/05/2021
    Excerpt:
    MGMT expression was inversely correlated with MGMTp methylation levels (− 0.506, p < 0.0001), and MGMT low expression were significantly associated with better patient survival.
    DOI:
    https://doi.org/10.1007/s11060-020-03675-6